Phase 2b Trial of Neovacs’ Investigational Lupus Immunotherapy on Track to Conclude in 2018 – Lupus News Today
Lupus News Today |
Phase 2b Trial of Neovacs' Investigational Lupus Immunotherapy on Track to Conclude in 2018
Lupus News Today A Phase 2b clinical trial assessing Neovacs' investigational immunotherapy for the treatment of systemic lupus erythematosus (SLE) is on schedule to deliver results by mid-2018, the company recently said. The announcement follows an independent review … |
